Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 12, 2001, Pages 2011-2018

  Argmann, Carmen A ^a   Van den Diepstraten, Caroline H ^a   Sawyez, Cynthia G ^a   Edwards, Jane Y ^a   Hegele, Robert A ^a   Wolfe, Bernard M ^a   Huff, Murray W ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Atherosclerosis; Lipoproteins; Macrophages; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; LIPID PEROXIDATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035571608     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq1201.099426     Document Type: Article

References (49)

1. Atherosclerosis: An inflammatory disease
2. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions
3. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaques
4. Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages
5. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II
6. CD36 is a receptor for oxidized low density lipoprotein
7. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein
8. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57B1/6 mice
9. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation
10. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
11. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A
12. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
13. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
14. Macrophage deactivating factor and transforming growth factors-β1-β2 and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ
15. Transforming growth factor β1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells
16. Role of transforming growth factor β in human disease
17. Transforming growth factor-β1 inhibits cytokine-mediated induction of human metalloelastase in macrophages
18. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor
19. Dietary fat and reduced levels of TGFβ-1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions
20. The cholesterol ester cycle in macrophage foam cells: Continual hydrolysis and re-esterification of cytoplasmic cholesterol esters
21. High density lipoproteins and arteriosclerosis: Role of cholesterol efflux and reverse cholesterol transport
22. Transforming growth factor β-1 inhibits scavenger receptor activity in THP-1 human macrophages
23. Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-γ
24. Transforming growth factor-β up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells
25. TGF-β increases cholesterol efflux and ABC-1 expression in macrophage derived foam cells: Opposing the effects of IFN-γ
26. Epidemiology of hypertriglyceridemia and cardiovascular disease
27. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins: A comparison of VLDL from subjects with types III, IV and V hyperlipoproteinemia
28. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density subfractions occurs by different mechanisms
29. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially following remnant formation
30. Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL
31. Pathogenesis and management of lipoprotein disorders
32. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
33. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
34. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic VLDL
35. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-γ
36. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP
37. Molecular and cell biology of TGFβ-1
38. Oxidized LDL increases and interferon-γ decreases expression of CD36 in human monocyte-derived macrophages
39. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
40. Induction of CD36 expression by oxidized LDL and IL-4 by a common signalling pathway dependent on protein kinase C and PPAR-γ
41. Structure, function and regulation of the ABC1 gene product
42. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
43. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis
44. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice
45. Acquisition of secretion of transforming growth factor β-1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1
46. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
47. Signaling of transforming growth factor-β family members through Smad proteins
48. Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions: Colocalization implicates TGF-β in fibrofatty lesion development
49. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions